Biotts

BIOTTS, a Polish-American biotech company, develops proprietary drugs in oncology, diabetology and pain utilizing unique formulations and drug delivery technologies. Biotts scientists have developed a breakthrough technology of universal transdermal therapeutic system MTC-Y (Multifunctional Transdermal Carrier-Y). The properties of the carrier increase the bioavailability of active substances several times, enabling them to penetrate through the skin into soft tissues and bones. The carrier can be easily modified to obtain targeted action in pathologically changed tissues. Thanks to the system, it is possible to reduce the therapeutic dose of the drug while maintaining its original effect and simultaneously reducing the side effects. In addition, the system enables the transport of one to several active substances, which makes it possible to design multi-component drugs.